Gelteq GELS
NASDAQ GELS
$0.53 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Gelteq (GELS) Capital Expenditures (2024)

Updated

Gelteq (GELS) recorded Capital Expenditures of -$2 billion in the year ended Jun 30, 2025, compared with -$2.08 billion a year earlier.

Analysis

Gelteq (GELS) Capital Expenditures (2024) Analysis & Trends

  • Per Business Quant data, GELS's Capital Expenditures was -$2.08 billion in the year ended Jun 30, 2024 and -$23.06 billion in the year ended Jun 30, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Iqvia Holdings 44.26 Bn 36.10 Bn 1.44 Bn 198.00 Mn
2 Medpace Holdings 17.42 Bn 15.48 Bn 201.64 Mn 23.91 Mn
3 Charles River Laboratories International 14.08 Bn 13.32 Bn 363.37 Mn 31.11 Mn
4 Icon 13.02 Bn 10.12 Bn 479.29 Mn -42.42 Mn
5 Fortrea Holdings 1.90 Bn 1.28 Bn 139.20 Mn 9.00 Mn
6 Ginkgo Bioworks Holdings 817.41 Mn 55.33 Mn 18.44 Mn 2.62 Mn
7 Evotec SE 608.00 Mn -965.22 Mn - -
8 Champions Oncology 69.59 Mn 45.24 Mn 7.70 Mn 55,000.00
9 MindWalk Holdings 62.13 Mn 26.34 Mn 1.61 Mn -55,941.69
10 Gelteq 5.68 Mn 3.44 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -2,038.38
API Access

Gelteq Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=GELS&period=max&api_key=YOUR_API_KEY